Perinatal Arterial Stroke Treated With Stromal Cells Intranasally "PASSIoN"

Not yet recruiting

Phase 1/2 Results N/A

Summary of Purpose

This study will assess safety and feasibility of bone marrow-derived allogeneic MSCs, administered by the nasal route, in neonates who suffered from PAIS.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 4 December 2017.

1 Jan 2018 8 Nov 2017 1 Nov 2019 1 Nov 2019 1 Dec 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available

Contacts